sulpiride has been researched along with Bone Loss, Osteoclastic in 1 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Y | 1 |
| Su, YA | 1 |
| Zhao, ZG | 1 |
| Gao, N | 1 |
| Huang, JZ | 1 |
| Tang, MQ | 1 |
| Li, KQ | 1 |
| Yang, FD | 1 |
| Yu, X | 1 |
| Si, TM | 1 |
1 trial available for sulpiride and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Biomarkers; Bone Remodeling; Bone Resorption; Female; Halo | 2015 |